TPIV200
Triple-negative breast cancer (TNBC) - second line
3Q 2018
09/30/2018
Phase 2 interim response data due 3Q 2018.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
